Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

REGENERON PHARMACEUTICALS, INC.

(REGN)
  Report
Real-time Estimate Cboe BZX  -  10:08:25 2023-02-02 am EST
746.26 USD   -1.55%
01/31Regeneron Announces Investor Conference Presentations
GL
01/31Regeneron Announces Investor Conference Presentations
GL
01/31Celltrion Files IPR Petition On Aflibercept Patent
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart REGENERON PHARMACEUTICALS, INC.
Upcoming events on REGENERON PHARMACEUTICALS, INC.
02/03/23 FY 2022 Earnings Release
02/03/23 | 08:30am FY 2022 Earnings Call
05/04/23 Q1 2023 Earnings Release (Projected)
08/03/23 Interim 2023 Earnings Release (Projected)
11/07/23 Q3 2023 Earnings Release (Projected)
02/08/24 FY 2023 Earnings Release (Projected)
Past events on REGENERON PHARMACEUTICALS, INC.
01/09/23 | 12:00pm JP Morgan Healthcare Conference
12/14/22 | 08:30am American Society of Hematology Meeting
12/13/22 American Society of Hematology Meeting - Abstract 3652
12/13/22 American Society of Hematology Meeting - Abstract #3992
12/12/22 | 05:30pm American Society of Hematology Meeting - Abstract #949
12/12/22 American Society of Hematology Meeting - Abstract #4873
12/12/22 American Society of Hematology Meeting - Abstract 4896
12/12/22 American Society of Hematology Meeting - Abstract #4551
12/12/22 American Society of Hematology Meeting - Abstract #4555
12/12/22 American Society of Hematology Meeting - Abstract #3601
Past dividends on REGENERON PHARMACEUTICALS, INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
5 872
5 788
1,5%
6 711
6 520
2,9%
7 863
7 816
0,61%
8 497
8 494
0,04%
16 072
15 679
2,5%
 
11 850
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
2 732
2 658
2,8%
3 110
2 959
5,1%
3 420
3 610
-5,3%
4 245
4 158
2,1%
9 835
9 709
1,3%
 
6 161
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
2 080
2 094
-0,70%
2 534
2 424
4,5%
2 210
2 285
-3,3%
3 577
3 485
2,6%
8 947
9 034
-0,96%
 
5 561
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
2 079
2 075
0,16%
2 554
2 543
0,39%
2 429
2 308
5,3%
3 810
3 582
6,4%
9 326
9 442
-1,2%
 
4 812
 
Net income
M $
Released
Forecast
Spread
1 199
1 438
-17%
2 444
2 257
8,3%
2 116
1 998
5,9%
3 513
3 160
11%
8 075
8 014
0,77%
 
4 166
 
EPS
$
Released
Forecast
Spread
10,3
12,6
-18%
21,3
19,7
7,9%
18,5
17,6
4,7%
30,5
28,0
9,0%
72,0
71,1
1,2%
 
36,3
 
Announcement Date02/08/201802/06/201902/06/202002/05/202102/04/2022-
Quarterly results
Fiscal Period : December2021 Q32021 Q42022 Q12022 Q22022 Q32022 Q4
Sales
M $
Released
Forecast
Spread
3 453
2 800
23%
4 952
4 526
9,4%
2 965
2 690
10%
2 857
2 797
2,1%
2 936
2 870
2,3%
 
3 113
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
2 057
1 314
57%
2 903
2 564
13%
1 558
1 376
13%
1 344
1 220
10%
1 488
1 344
11%
 
1 336
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
1 847
1 278
45%
2 640
2 601
1,5%
1 483
1 273
17%
1 285
1 124
14%
1 413
1 313
7,6%
 
1 344
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
1 817
1 392
30%
2 503
2 649
-5,5%
1 061
1 185
-10%
963
1 116
-14%
1 510
984
53%
 
1 154
 
Net income
M $
Released
Forecast
Spread
1 632
1 152
42%
2 229
2 108
5,7%
974
1 038
-6,2%
852
794
7,4%
1 316
845
56%
 
1 060
 
EPS
$
Released
Forecast
Spread
14,3
10,7
34%
19,7
19,4
1,3%
8,61
8,77
-1,9%
7,47
7,38
1,3%
11,7
7,93
47%
 
9,23
 
Announcement Date11/04/202102/04/202205/04/202208/03/202211/03/2022-
Previous year Next Year
Upcoming sector events for REGENERON PHARMACEUTICALS, INC.
More events
Past sector events for REGENERON PHARMACEUTICALS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise